Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
2018 · New England Journal of Medicine · 5,403 citations
https://doi.org/10.1056/nejmoa1709866
C
Carl H. June
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.4K
Papers
144.2K
Citations
177
h-index
648
i10-index
Carl H. June is an academic researcher from California University of Pennsylvania. The author has contributed to research in topics: CAR-T cell therapy research & Immune Cell Function and Interaction & Immunotherapy and Immune Responses. The author has an h-index of 177, co-authored 1205 publications.
ORCID: 0000-0003-0241-3557Papers by this author
worksChimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 · New England Journal of Medicine · 5,279 citations
https://doi.org/10.1056/nejmoa1407222
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 · New England Journal of Medicine · 3,436 citations
https://doi.org/10.1056/nejmoa1215134
CAR T cell immunotherapy for human cancer
2018 · Science · 2,976 citations
https://doi.org/10.1126/science.aar6711
A human memory T cell subset with stem cell–like properties
2011 · Nature Medicine · 1,884 citations
https://doi.org/10.1038/nm.2446
CRISPR-engineered T cells in patients with refractory cancer
2020 · Science · 1,396 citations
https://doi.org/10.1126/science.aba7365
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat